# Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions

> **NCT06618248** · NA · RECRUITING · sponsor: **Dongguan TT Medical** · enrollment: 280 (estimated)

## Conditions studied

- Coronary Bifurcation Lesion

## Interventions

- **COMBINATION_PRODUCT:** Sirolimus coated balloon angioplasty
- **COMBINATION_PRODUCT:** Paclitaxel coated balloon angioplasty

## Key facts

- **NCT ID:** NCT06618248
- **Lead sponsor:** Dongguan TT Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-20
- **Primary completion:** 2025-09
- **Final completion:** 2027-03
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2024-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618248, "Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06618248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*